A

Alkermes ( Formely Elan Pharma )

2359 employees

Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.

Investor insights

Sectors invested in

Non Profit4
Charity2
Life Science1
psychiatrist1
advocacy1
mental health1
psychiatry1
mental illness1
Elder Care1
Social1
legislation1
research1
Law Enforcement1
public policy1
data1
Legal1
criminal justice1
Public Relations1
public safety1
Providing Resources to Employers1

Funding rounds participated in

$38M sweet spot round size

Most of their 6 investments are in rounds between $38M and $38M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
serious mental illness
addiction
District Sales
CNS
Research & Development
IT
Pharmaceutical
Human Resources
Information technology
oncology
Marketing
R&D
Health Care
Sales
Addiction
Pharma
Medical Affairs
Manufacturing
Regional Sales
biotech

Date founded

1987

Investments made

T

The Council of State Governments Justice Center raised undisclosed on August 31, 2023

Investors: Alkermes ( Formely Elan Pharma )

A

American Psychiatric Association raised undisclosed on August 31, 2023

Investors: Alkermes ( Formely Elan Pharma )

U

Undisclosed raised undisclosed on August 31, 2023

Investors: Alkermes ( Formely Elan Pharma )

C

Caregiver Action Network raised undisclosed on August 31, 2023

Investors: Alkermes ( Formely Elan Pharma )

A

APA Foundation's Center for Workplace Mental Health raised undisclosed on August 31, 2023

Investors: Alkermes ( Formely Elan Pharma )

C

Civitas Therapeutics raised $38M on September 11, 2013

Investors: Bay City Capital, Canaan, RA Capital Management, L.P., Longitude Capital and Alkermes ( Formely Elan Pharma )

FAQ